Under the program, a customer can submit tissue samples to NanoString to be analyzed using the 1000-plex RNA panel and receive a complete data package.

The spatial molecular imager platform provides sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from cells within morphologically intact tissue samples. The platform leverages the company's Hyb & Seq chemistry optimized for in situ spatial analysis.

The new platform complements NanoString's other high-plex, high-throughput technologies: the GeoMX digital spatial profiler, which provides spatial profiling of RNA and protein targets, and the GeoMx whole transcriptome atlas.

Nanostring will be discussing its technology at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting.

NanoString tech helps profile cancer-immune states in tumors
A new article in Nature Medicine provides insights into cancer tissues by using NanoString Technology's GeoMx Digital Spatial Profiler and its...

Researchers innovate drug discovery screening techniques
Researchers from around the globe gathered to discuss innovations in laboratory techniques such as phenotypic profiling and flow cytometry for drug discovery...

NanoString forms group to set spatial research standards
NanoString Technologies has formed a leadership network to pioneer the application of spatial biology in large studies.

NanoString launches readout technology for NGS
NanoString Technologies has released Cancer Transcriptome Atlas, a new product based on the company's GeoMx digital spatial profiler platform that's optimized...

NanoString debuts products to push COVID-19 research
NanoString Technologies has debuted new products that advance COVID-19 research by studying the immune response of the SARS-CoV-2 virus.